Parth Narendran is based at the University of Birmingham, and at Queen Elizabeth Hospital, Birmingham. He qualified from Kings College London and undertook his post-graduate clinical training in Manchester, Bristol and London. He conducted his PhD studies on the immune mechanisms underlying the development of type 1 diabetes whilst at Bristol. He was subsequently awarded a JDRF post-doctoral fellowship in Melbourne, Australia.
Parth’s clinical interests focus on type 1 diabetes and he supports the type 1 services at the Queen Elizabeth Hospital, Birmingham. These include a structured education programme called Dose Adjustment for Normal Eating (DAFNE), the adolescent transition, insulin pump, glucose sensing and islet/pancreas transplant services. Supporting patients to exercise is a core interest of the service.
Parth’s research interests also focus on type 1 diabetes. He has a long-standing interest in preserving the function of insulin producing pancreatic beta cells in type 1 diabetes. More recently he has been involved programmes for detecting people at risk of getting type 1 diabetes so that they can be offered clinical trials for prevention of this condition.